Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India

International Journal of Cancer

Volumn 125, Issue 7, 2009, Pages 1663-1670

  Dey, Subhojit ^a   Boffetta, Paolo ^b   Mathews, Anitha ^c   Brennan, Paul ^b   Soliman, Amr ^a   Mathew, Aleyamma ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c REGIONAL CANCER CENTRE   (India)

Author keywords

Breast cancer; Estrogen receptor; India

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST FEEDING; CANCER CENTER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DEVELOPING COUNTRY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MARRIAGE; MOSLEM; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL STATUS;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; INDIA; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; MOTOR ACTIVITY; ODDS RATIO; QUESTIONNAIRES; RECEPTORS, ESTROGEN; RELIGION; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; RURAL POPULATION; SOCIOECONOMIC FACTORS; TUMOR MARKERS, BIOLOGICAL; URBAN POPULATION;

EID: 68549139985     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24460     Document Type: Article

References (64)

1. Hulka BS, Chambless LE, Wilkinson WE, Deubner DC, McCarty KS, Sr, McCarty KS, Jr. Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol 1984;119:692-704.
2. Hislop TG, Coldman AJ, Elwood JM, Skippen DH, Kan L. Relationship between risk factors for breast cancer and hormonal status. Int J Epidemiol 1986;15:469-76.
3. McTiernan A, Thomas DB, Johnson LK, Roseman D. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst 1986;77:849-54.
4. Stanford JL, Szklo M, Boring CC, Brinton LA, Diamond EA, Greenberg RS, Hoover RN. A case-control study of breast cancer stratified by estrogen receptor status. Am J Epidemiol 1987;125:184-94.
5. Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD. Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 1989;59:119-25.
6. Lonning PE. Adjuvant endocrine treatment of early breast cancer. Hematol Oncol Clin North Am 2007;21:223-38.
7. Ferno M. Prognostic factors in breast cancer: a brief review. Anticancer Res 1998;18:2167-71.
8. Horwitz KB, Koseki Y, McGuire WL. Estrogen control of progesterone receptor in human breast cancer: role of estrdiol and antiestrogen. Endocrinology 1978;103:1742-51.
9. Ruder AM, Lubin F, Wax Y, Geier A, Alfundary E, Chetrit A. Estrogen and progesterone receptors in breast cancer patients: epidemiologic characteristics and survival differences. Cancer 1989;64:196-202.
10. Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR. Progesterone and estrogen receptors andmammary neoplasia in the IowaWomen's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995;4:319-26.
11. Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, Dubrow R. Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 1997;146:307-14.
12. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000;151:703-14.
13. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218-28.
14. Chen WY, Colditz GA. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer. Nat Clin Pract Oncol 2007;4:415-23.
15. Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, Chow LW, Masood S, Ramsey SD, Carlson RW. Breast cancer in limited-resource countries: an overview of the breast health global initiative 2005 guidelines. Breast J 2006;12 (Suppl 1):S3-S15.
16. Eniu A, Carlson RW, Aziz Z, Bines J, Hortobagyi GN, Bese NS, Love RR, Vikram B, Kurkure A, Anderson BO. Global summit treatment and allocation of resources panel. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J 2006;12:S38-S53.
17. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer incidence in five continents, vol. 8. Lyon: IARC Scientific Publications, 2002. 155 p.
18. Redkar AA, Sampat MB, Chinoy RF, Kabre SS, Mittra I. Differences in oestrogen receptor status and histological grade of breast cancer in different religious communities in Bombay. Indian J Cancer 1991;28:124-30.
19. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast 2000;9:267-70.
20. Ahmad R, Shaikh H, Hasan SH. Is carcinoma breast a different disease in Pakistani population? J Pak Med Assoc 1997;47:114-16.
21. Chow LW, Ho P. Hormonal receptor determination of 1052 Chinese breast cancers. J Surg Oncol 2000;75:172-5.
22. Nomura Y, Tashiro H, Hamad Y, Shigematsu T. Relationship between estrogen receptors and risk factors of breast cancer in Japanese pre- and post- menopausal patients. Breast Cancer Res Treat 1984;4:37-43.
23. Tewari M, Pradhan S, Singh U, Shukla HS. Estrogen and progesterone receptors status in breast cancer: effect of oral contraceptive pills and hormone replacement therapy. Breast 2007;16:540-5.
24. Agarwal N, Deka D, Takkar D. Contraceptive status and sexual behavior in women over 35 years of age in India. Adv Contracept 1999;15:235-44.
25. International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3), 2005-06: India, vol. 1. Mumbai: IIPS. 2007.
26. Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Begin LR, et al. Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 2004;10:2029-34.
27. Bittles AH, Hussain R. An analysis of consanguineous marriage in the Muslim population of India at regional and state levels. Ann Hum Biol 2000;27:163-71.
28. Gilani GM, Kamal S. Risk factors for breast cancer in Pakistani women aged less than 45 years. Ann Hum Biol 2004;31:398-407.
29. Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 2002;71:595-606.
30. Devesa SS, Diamond EL. Association of breast cancer and cervical cancer incidence with income and education among whites and blacks. J Natl Cancer Inst 1980;65:515-28.
31. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996;17:47-67.
32. Liu L, Deapen D, Berstein L. Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 1998;9:369-80.
33. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703-11.
34. Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA, Remington PL. Socioeconomic risk factors for breast cancer: distinguishing individual and community-level effects. Epidemiology 2004;15:442-50.
35. Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 2007;17:304-12.
36. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, Suzuki Y, Ohmori K, Nishino Y, Tsuji I. Obesity and risk of cancer in Japan. Int J Cancer 2005;113:148-57.
37. Tung HT, Tsukuma H, Tanaka H, Kinoshita N, Koyama Y, Ajiki W, Oshima A, Koyama H. Risk factors for breast cancer in Japan, with special attention to anthropolometric measurements and reproductive factors. Jpn J Clin Oncol 1999;29:137-46.
38. Shu XO, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA, Herbert JR, Ruan Z, Gao YT, Zheng W. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 2001;94:449-55.
39. Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, Kuroishi T, Miura S, Tokudome S. Effect of body size on breast-cancer risk among Japanese women. Int J Cancer 1999;80:349-55.
40. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10:15-32.
41. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
42. Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995;6:137-41.
43. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR, 2007.
44. International Agency for Research on Cancer. IARC Handbooks of cancer prevention, vol. 6: weight control and physical activity. Lyon: IARC, 2002.
45. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996;88:756-8.
46. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast-cancer risk. Int J Cancer 1992;52:511-16.
47. Reneham AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I. IGF binding protein-3 and cancer risk. Systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
48. Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas J, Russo IH. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev 2006;15:306-42.
49. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982;2:5-73.
50. Russo J, Russo IH. Breast development, hormones and cancer. Adv Exp Med Biol 2008;630:52-6.
51. Russo J, Balogh GA, Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 2008;17:51-66.
52. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
53. Gupta PB, Kuperwasser C. Contributions of estrogens to ER-negative breast tumor growth. J Steroid Biochem Mol Biol 2006;102:71-8.
54. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985;74:741-45.
55. Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF. Relationship between serum hormone concentration, reproductive history, alcohol consumption and genetic polymorphisms in premenopausal women. Int J Cancer 2002;102:172-8.
56. Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A, Campbell WS, Franz C, Kahle L, Taylor PR. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 1995;4:381-6.
57. Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, Simon MS, Strom BL, Press MF, Folger SG, Burkman RT, Deapen D, et al. Breast cancer risk and hormone receptor status in old women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:1723-30.
58. Lipworth L, Bailey LR, Trichopoulos D. History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 2000;92:302-12.
59. Sonawane BR. Chemical contaminants in human milk: an overview. Environ Health Perspect 1995;103:197-205.
60. Smith D. Worldwide trends in DDT levels in human breast milk. Int J Epidemiol 1999;28:179-88.
61. Martin FL, Cole KJ, Weaver G, Hong GS, Lam BC, Balaram P, Grover PL, Phillips DH. Genotoxicity of human breast milk from different countries. Mutagenesis 2001;16:401-6.
62. Russo J, Russo IH. Toward a physiologic approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994;3:353-64.
63. Friedenreich CM, Cust AE. Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 2008;42:636-47.
64. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Berstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000;9:681-7.